Tantum Verde Mouthwash 0.15% Benzydamine Hydrochloride Bottle 240ml

NAME
GREEN TANTUM 0.15% MOUTHWASH

PHARMACOTHERAPEUTIC CATEGORY
Stomatological.

ACTIVE PRINCIPLES
Benzydamine hydrochloride.

EXCIPIENTS
Glycerol, ethanol (96%), saccharin, methyl parahydroxybenzoate, sodium bicarbonate, mint flavor, polysorbate 20, quinoline yellow (E 104), patent blue V (E 131), purified water.

INDICATIONS
Symptomatic treatment of irritative-inflammatory states also associated with oropharyngeal pain (eg gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy.

CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity to benzydamine or to any of the excipients listed.

DOSAGE
Pour 15 ml into the measuring cup to be used, 2-3 times a day, in pure or diluted form (in this case add 15 ml of water to the measuring cup). Do not exceed the recommended dose.

STORAGE
This medicine does not require any special storage conditions.

WARNINGS
The use of the product, especially if prolonged, can give rise to sensitization phenomena. In this case, stop the treatment and institute appropriate therapy. In a limited number of patients, oropharyngeal ulcerations can be a sign of more serious pathologies. The use of benzydamine is not recommended in patients with hypersensitivity to acetylsalicylic acid or to other NSAIDs. The drug should be administered with caution in subjects who have had episodes of bronchial asthma in the past, as bronchospasm phenomena may occur in this type of patients. The medicine contains parahydroxybenzoates which can cause allergic reactions (including delayed). For those who carry out sporting activities: the use of medicines containing ethyl alcohol can determine positive doping tests in relation to the alcohol concentration limits indicated by some sports federations.

INTERACTIONS
No interaction studies have been performed.

SIDE EFFECTS
The list below shows the undesirable effects classified for systems and organs according to MedDRA. Undesirable effects are listed using the following frequency scales: very common (> = 1/10); common (> = 1/100, <1/10); uncommon (> = 1/1000, <1/100); rare (> = 1 / 10,000, <1/1000); very rare (<1 / 10,000); not known. Disorders of the immune system. Rare: hypersensitivity reaction '; not known: anaphylactic reaction. Respiratory, thoracic, mediastinal disorders. Very rare: laryngospasm. Gastrointestinal disorders. Rare: burning in the mouth, dry mouth. Skin and subcutaneous tissue disorders. Uncommon: photosensitivity '; very rare: angioedema. The reporting of suspected adverse reactions that occur after the authorization of the drug is important, as it allows continuous monitoring of the benefit / risk ratio of the drug.

PREGNANCY AND BREASTFEEDING
There are no data on the use of benzydamine in pregnancy or during lactation. The excretion of the product in breast milk has not been studied. Studies conducted on animals with reference to the effects in pregnancy and lactation are insufficient and therefore the potential risk for humans cannot be assessed. During pregnancy and lactation the drug should not be used.